Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitro.
about
Outer membrane vesicles as platform vaccine technologyExtracellular Vesicles: Role in Inflammatory Responses and Potential Uses in Vaccination in Cancer and Infectious DiseasesThe Role of the Immune Response in Chlamydia trachomatis Infection of the Male Genital Tract: A Double-Edged SwordOuter membrane vesicles displaying engineered glycotopes elicit protective antibodiesMembrane vesicle production by Chlamydia trachomatis as an adaptive responseAntibody-mediated immunity induced by engineered Escherichia coli OMVs carrying heterologous antigens in their lumen.On-chip immunoelectrophoresis of extracellular vesicles released from human breast cancer cells.Evaluation of Borrelia burgdorferi BbHtrA Protease as a Vaccine Candidate for Lyme Borreliosis in Mice.Anti-chlamydial IgG Neutralizing Ability in Nonzoonotic Atypical Community Acquired Respiratory Tract Infections.Profiling and validation of individual and patterns of Chlamydia trachomatis-specific antibody responses in trachomatous trichiasis.Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research.Microbial biosynthesis of designer outer membrane vesicles.Vaccinology: The art of putting together the right ingredientsCell membrane-derived nanomaterials for biomedical applications.Bacterial serine protease HtrA as a promising new target for antimicrobial therapy?The M278 Major Outer Membrane Peptide Encapsulated in the Poly(lactic acid)-Poly(ethylene glycol) Nanoparticulate Self-Adjuvanting Delivery System Protects Mice Against a Genital Tract Challenge by Stimulating Robust Systemic and Local Mucosal Immune
P2860
Q26766539-374B4F91-4F33-45F2-8476-ADCCF64B0A3CQ26783960-A9683BCD-1EB5-4A14-86E0-CAD4B6B7D675Q26851537-9F8B9488-DD03-4C3A-A367-9426398EC3B2Q28831290-72A044B0-E5B1-4599-B94A-7AE579EB6A57Q33730339-4B5B2A21-2E02-4A27-A0A7-6B1804B4C832Q34037511-607F6670-65D6-46BA-BCA5-ECA790DDB6ACQ35557646-D06EC005-3C16-4B1B-8895-71DFE80E592BQ35664261-5135090A-BAEB-49ED-A641-4424E677BF04Q35685740-956FF0CE-00C8-4800-94B9-F53C421986D1Q37695434-11641FBC-47AB-4D41-A18F-482C8E0820DFQ37712799-E509460D-6B9C-45D4-AD84-56C083ADE864Q38199270-4FB619E7-B705-456F-92E1-AD8D5FE7B790Q38922448-3AD7A90C-EC0C-451A-A99B-09549BEFAE22Q39178313-8ACF15A8-D3B7-423E-A3D6-5FDE72A29792Q42332065-85DCD8F6-B3A1-48FB-BD54-40B776EAAB5CQ58122056-2B1BC7CD-06D1-4225-9215-AE62A990D528
P2860
Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitro.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Recombinant outer membrane ves ...... chlamydial infection in vitro.
@en
Recombinant outer membrane ves ...... chlamydial infection in vitro.
@nl
type
label
Recombinant outer membrane ves ...... chlamydial infection in vitro.
@en
Recombinant outer membrane ves ...... chlamydial infection in vitro.
@nl
prefLabel
Recombinant outer membrane ves ...... chlamydial infection in vitro.
@en
Recombinant outer membrane ves ...... chlamydial infection in vitro.
@nl
P2093
P2860
P50
P356
P1476
Recombinant outer membrane ves ...... chlamydial infection in vitro.
@en
P2093
Donatello Laera
Elisabetta Frigimelica
Elvira Ianni
Erika Bartolini
Fabiola Giusti
Giuliano Galli
Manuela Donati
Nathalie Norais
Oretta Finco
Renata Grifantini
P2860
P356
10.3402/JEV.V2I0.20181
P577
2013-05-06T00:00:00Z